AURA compared with VOR: revenue, margins and what each company keeps, and the suppliers and customers both name

AURAAura Biosciences, Inc.

Mkt capRevenueRevenue

VORVor Biopharma Inc.

Mkt capRevenueRevenue

Compare

AURAAura Biosciences, Inc.

VORVor Biopharma Inc.

Price

Mkt cap

Revenue

Supply-chain overlap

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

direct ties · both sidesSources ›

direct ties · both sides

Only AURA 0

None

Shared 0

No disclosed counterparties: AURA.

Only VOR 3

—RemeGenunlistedsupplier

—The Trustees of Columbia University in the City of New Yorkunlistedcustomer

—U.S. Department of Health and Human Services, as represented by National Cancer Institute of the National Institutes of Healthunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

AURAAura Biosciences, Inc.

6.36· pre 6.36· delayed

Mkt cap$689.6M

VORVor Biopharma Inc.

18.65· pre 18.55· delayed

Pre-marketNov 5 '26delayed

Mkt cap$1.2B

Compare

Pre-marketNov 5 '26delayed

AURAAura Biosciences, Inc.

VORVor Biopharma Inc.

6.36pre 6.36delayed

Price

18.65pre 18.55delayed

$689.6M

Mkt cap

$1.2B

AURA6.36vsVOR18.65Pre-marketNov 5 '26delayed